| Sep 21, 2026 | John Leite | GLOBAL CHIEF COMMERCIAL OFF | SELL | 4.015K | $40.00 | $161K |
| Sep 14, 2026 | Jens Holstein | DIRECTOR | SELL | 5.000K | $40.95 | $205K |
| Sep 2, 2026 | Phillip Febbo | CHIEF SCIENTIFIC & MED OFFICER | SELL | 16.749K | $43.45 | $728K |
| Sep 2, 2026 | Rebecca Chambers | CHIEF FINANCIAL OFFICER | SELL | 7.255K | $43.98 | $319K |
| Sep 2, 2026 | Annie McGuire | EVP, GENERAL COUNSEL | SELL | 6.469K | $43.98 | $285K |
| Sep 1, 2026 | Muna Bhanji | DIRECTOR | SELL | 1.864K | $42.97 | $80K |
| Jun 18, 2026 | KARIN EASTHAM | DIRECTOR | SELL | 3.729K | $52.89 | $197K |
| Jun 2, 2026 | Annie McGuire | EVP, GENERAL COUNSEL | SELL | 6.468K | $48.76 | $315K |
| Jun 2, 2026 | Rebecca Chambers | CHIEF FINANCIAL OFFICER | SELL | 7.254K | $48.75 | $354K |
| Jun 2, 2026 | Marc Stapley | CHIEF EXECUTIVE OFFICER | SELL | 9.012K | $43.29 | $2.3M |
| Jun 2, 2026 | John Leite | GLOBAL CHIEF COMMERCIAL OFF | SELL | 18.034K | $49.56 | $894K |
| May 22, 2026 | Jonathan Wygant | VP, CHIEF ACCOUNTING OFFICER | SELL-OPTIONS | — | $35.10 | $494K |
| May 20, 2026 | ROBERT EPSTEIN | DIRECTOR | SELL | 10.000K | $44.01 | $440K |
| May 6, 2026 | Annie McGuire | SVP, GENERAL COUNSEL | SELL | 10.204K | $39.02 | $398K |